Highlights
- Market Cap
- $3.62B
- Enterprise Value
- $3.23B
- EPS (TTM)
- $0.07
- PE Ratio
- 1,095.00
- Total Revenue (TTM)
- $305.11M
- Gross Profit (TTM)
- $208.46M
- EBITDA (TTM)
- $18.38M
- Year Range
- $61.96 - $138.70
- Target Price
- $130.33
- ROA (TTM)
- 0.51%
- ROE (TTM)
- 0.68%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in BillionToOne, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
BillionToOne, Inc
- 1D
- 12.59%
- 1M
- 3.42%
- YTD
- -3.54%
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Nov 6, 2025, BLLN's average daily return is -0.17%, while the average monthly return is -4.18%.
Historically, 60% of months were positive and 40% were negative. The best month was Nov 2025 with a return of +19.5%, while the worst month was Dec 2025 at -37.1%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 1 months.
On a daily basis, BLLN closed higher 49% of trading days. The best single day was Jan 12, 2026 with a return of +15.4%, while the worst single day was Feb 23, 2026 at -15.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.82% | -7.49% | 3.42% | -3.54% | |||||||||
| 2025 | 19.50% | -37.13% | -24.88% |
Benchmark Metrics
BillionToOne, Inc has an annualized alpha of -25.28%, beta of 1.98, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since November 07, 2025.
- This stock captured 954.03% of S&P 500 Index gains and 398.51% of its losses — amplifying both gains and losses, but participating more in upside than downside.
- R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -25.28%
- Beta
- 1.98
- R²
- 0.09
- Upside Capture
- 954.03%
- Downside Capture
- 398.51%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for BillionToOne, Inc (BLLN) and compare them to a chosen benchmark (S&P 500 Index).
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the BillionToOne, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the BillionToOne, Inc was 50.81%, occurring on Mar 12, 2026. The portfolio has not yet recovered.
The current BillionToOne, Inc drawdown is 39.36%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -50.81% | Dec 1, 2025 | 70 | Mar 12, 2026 | — | — | — |
| -17.8% | Nov 7, 2025 | 5 | Nov 13, 2025 | 6 | Nov 21, 2025 | 11 |
| -1.58% | Nov 26, 2025 | 1 | Nov 26, 2025 | 1 | Nov 28, 2025 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of BillionToOne, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how BillionToOne, Inc is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for BLLN, comparing it with other companies in the Diagnostics & Research industry. Currently, BLLN has a P/E ratio of 1,095.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BLLN relative to other companies in the Diagnostics & Research industry. Currently, BLLN has a P/S ratio of 11.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BLLN in comparison with other companies in the Diagnostics & Research industry. Currently, BLLN has a P/B value of 7.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |